China Vaccinates 8 Million For H1N1, Beijing To Give Shots To All
This article was originally published in PharmAsia News
China's nationwide H1N1 flu vaccination program has reached more than 8 million people, with another 39 million doses approved and waiting to be distributed. The Ministry of Health counts about 55,000 confirmed cases of the flu, more than 75 percent of them recovered, but 16 have died of it on the mainland. With the danger of the flu expected to last through March, health authorities have expanded plans in Beijing to inoculate all residents, regardless of priority. (Click here for more
You may also be interested in...
The Belgian biotech has managed to attract considerable sums from venture capitalists over the past couple of years amid hopes that its two next-generation immunotherapies will be best-in-class agents.
Cipla is celebrating an “important milestone” for the company after the successful completion of a Phase III clinical trial comparing its proposed Advair generic with GSK’s brand in the US. Management has cautioned that approval will be a way off yet, however.
FDA requests immediate removal of ranitidine OTC and Rx drugs after third-party testing finds contaminant NDMA increases during storage, especially at higher temperatures. CDER Director Janet Woodcock asks firms to reformulate products to be stable as the ingredient remains approved.